Prevalence of Cirrhosis Higher in Transgender Versus Cisgender Adults

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 29, 2024 -- Transgender adults have higher prevalence of cirrhosis, but they do not have increased incidence of liver-related outcomes or all-cause mortality, according to a study published online June 25 in the American Journal of Gastroenterology.

Hirsh Elhence, from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues identified all transgender and cisgender adults to calculate the age-standardized prevalence of cirrhosis. Age-standardized incidence densities of liver-related outcomes (decompensation, transplantation, and hepatocellular carcinoma) and all-cause mortality were calculated among those with incident cirrhosis diagnoses. Using inverse probability treatment weighting to balance transgender and cisgender populations on demographic and clinical characteristics, five-year survival was examined.

Overall, 0.07 percent of the 64.6 million adults were transgender, and 0.09 percent of the 329,251 adults with cirrhosis were transgender. The researchers found that the prevalence of cirrhosis was higher for transgender versus cisgender adults (1,285 versus 561 per 100,000). Among those with cirrhosis, compared with cisgender adults, transgender adults had higher proportions of anxiety (70.7 versus 43.2 percent), depression (66.4 versus 38.4 percent), HIV/AIDS (8.5 versus 1.6 percent), and alcohol (57.5 versus 51.0 percent) and viral (30.5 versus 24.2 percent) etiologies, although confidence intervals were overlapping. Similar incidence densities were seen for death, decompensation, and liver transplantation between transgender and cisgender individuals. In addition, similar five-year survival probabilities were seen for transgender and cisgender individuals.

"Our findings suggest that transgender individuals represent a vulnerable population that require specific attention from clinicians and researchers alike," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-30 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords